The estimated Net Worth of Shari L O'quinn is at least $12 Tysiąc dollars as of 29 February 2016. Shari quinn owns over 4,000 units of Endologix stock worth over $11,995 and over the last 9 years Shari sold ELGX stock worth over $0.
Shari has made over 1 trades of the Endologix stock since 2016, according to the Form 4 filled with the SEC. Most recently Shari sold 4,000 units of ELGX stock worth $880 on 29 February 2016.
The largest trade Shari's ever made was selling 4,000 units of Endologix stock on 29 February 2016 worth over $880. On average, Shari trades about 1,000 units every 0 days since 2016. As of 29 February 2016 Shari still owns at least 54,522 units of Endologix stock.
You can see the complete history of Shari quinn stock trades at the bottom of the page.
Shari's mailing address filed with the SEC is 4239 E DUBOIS CT, , GILBERT, AZ, 85298.
Over the last 22 years, insiders at Endologix have traded over $72,068,611 worth of Endologix stock and bought 306,824 units worth $2,023,811 . The most active insiders traders include International, L.P. Elliott, Associates, L.P. Elliott oraz Capital Management Lp Camber. On average, Endologix executives and independent directors trade stock every 27 days with the average trade being worth of $13,088. The most recent stock trade was executed by Dan Lemaitre on 4 September 2020, trading 51,844 units of ELGX stock currently worth $2,592.
Endologix, Inc. engages in the research, development, manufacture, and trade of medical devices for the treatment of aortic disorders such as abdominal aortic aneurysms (AAA). Its products include AFX Endovascular AAA System, Nellix and Ovation. The company was founded in March 1992 and is headquartered in Irvine, CA.
Endologix executives and other stock owners filed with the SEC include: